| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,797 |
15,730 |
$6.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,402 |
45,236 |
$5.42M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
39,604 |
36,083 |
$5.01M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,357 |
18,344 |
$2.75M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,165 |
10,832 |
$1.21M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
9,065 |
7,312 |
$1.12M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,420 |
5,544 |
$1.04M |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,056 |
4,074 |
$1.03M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,878 |
4,082 |
$1.00M |
| G0378 |
Hospital observation service, per hour |
13,405 |
7,684 |
$944K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,900 |
2,394 |
$661K |
| 77386 |
|
2,145 |
179 |
$579K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,324 |
3,242 |
$527K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,599 |
4,244 |
$514K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,786 |
2,589 |
$451K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,585 |
3,638 |
$448K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,349 |
2,080 |
$420K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,682 |
1,433 |
$386K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
731 |
665 |
$349K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,484 |
1,241 |
$321K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
63,367 |
53,811 |
$307K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,744 |
2,583 |
$271K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,237 |
7,412 |
$267K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,273 |
2,052 |
$262K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,885 |
2,215 |
$261K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
390 |
382 |
$235K |
| 59025 |
Fetal non-stress test |
1,507 |
1,000 |
$218K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,728 |
3,280 |
$200K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,274 |
4,072 |
$186K |
| 93356 |
|
954 |
864 |
$185K |
| 76642 |
|
1,380 |
1,249 |
$159K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,326 |
9,123 |
$157K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,714 |
1,556 |
$155K |
| 95811 |
|
231 |
215 |
$149K |
| 95708 |
|
212 |
134 |
$147K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
945 |
817 |
$141K |
| 77336 |
|
1,503 |
652 |
$140K |
| 70496 |
|
684 |
577 |
$133K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
508 |
442 |
$129K |
| 97162 |
|
2,491 |
2,117 |
$126K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
315 |
279 |
$122K |
| 78431 |
|
278 |
241 |
$120K |
| 76820 |
|
1,947 |
745 |
$117K |
| 77300 |
|
329 |
265 |
$110K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
526 |
444 |
$100K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,582 |
922 |
$100K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,402 |
1,992 |
$94K |
| 77334 |
|
336 |
251 |
$94K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,050 |
1,176 |
$93K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,346 |
1,169 |
$89K |
| 76830 |
Ultrasound, transvaginal |
1,156 |
1,061 |
$84K |
| 93970 |
|
690 |
602 |
$79K |
| 36224 |
|
31 |
29 |
$76K |
| 97161 |
|
1,391 |
1,146 |
$68K |
| 93971 |
|
1,148 |
1,004 |
$68K |
| 84484 |
|
25,720 |
14,715 |
$66K |
| 93017 |
|
908 |
801 |
$63K |
| 71250 |
|
879 |
769 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,765 |
4,398 |
$60K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
531 |
414 |
$56K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,545 |
2,502 |
$53K |
| 93458 |
|
46 |
40 |
$51K |
| 12001 |
|
371 |
311 |
$50K |
| 72131 |
|
1,134 |
955 |
$50K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
352 |
318 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
78,732 |
64,060 |
$46K |
| 71046 |
Radiologic examination, chest; 2 views |
3,909 |
3,525 |
$45K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
32,419 |
27,048 |
$43K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,692 |
4,480 |
$42K |
| 19083 |
|
84 |
70 |
$39K |
| 88307 |
|
744 |
466 |
$38K |
| 82805 |
|
1,903 |
1,448 |
$38K |
| 71045 |
Radiologic examination, chest; single view |
18,754 |
16,143 |
$38K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
297 |
261 |
$35K |
| 70491 |
|
129 |
113 |
$35K |
| 80053 |
Comprehensive metabolic panel |
7,661 |
5,965 |
$35K |
| 10060 |
|
246 |
229 |
$35K |
| 97165 |
|
940 |
713 |
$34K |
| 97166 |
|
1,007 |
756 |
$32K |
| J3490 |
Unclassified drugs |
5,303 |
3,615 |
$31K |
| 88341 |
|
832 |
456 |
$30K |
| 96367 |
|
922 |
658 |
$30K |
| 86850 |
|
2,072 |
1,774 |
$30K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,914 |
1,570 |
$29K |
| 80069 |
|
5,251 |
3,245 |
$29K |
| 80076 |
|
17,952 |
15,332 |
$29K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,342 |
1,289 |
$29K |
| 77065 |
Tomosynthesis, mammo |
940 |
765 |
$28K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
218 |
89 |
$27K |
| 88184 |
|
359 |
328 |
$26K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
74 |
71 |
$25K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26,755 |
23,235 |
$25K |
| 77066 |
Tomosynthesis, mammo |
781 |
704 |
$24K |
| 88185 |
|
622 |
328 |
$23K |
| 93325 |
|
297 |
263 |
$23K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
311 |
224 |
$23K |
| 58661 |
|
12 |
12 |
$22K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
112 |
105 |
$22K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
163 |
118 |
$21K |
| 76536 |
|
211 |
197 |
$21K |
| 22551 |
|
20 |
12 |
$20K |
| 86900 |
|
2,327 |
2,002 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
20,975 |
12,538 |
$17K |
| 76801 |
|
316 |
292 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,642 |
9,320 |
$17K |
| 97535 |
Self-care/home management training, each 15 minutes |
774 |
398 |
$17K |
| 97163 |
|
320 |
308 |
$17K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
538 |
178 |
$16K |
| 93880 |
|
223 |
197 |
$16K |
| 72132 |
|
207 |
173 |
$16K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
362 |
342 |
$14K |
| 72128 |
|
565 |
473 |
$14K |
| 74018 |
|
628 |
524 |
$13K |
| 70486 |
|
536 |
472 |
$13K |
| 72100 |
|
598 |
530 |
$13K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14,882 |
12,945 |
$13K |
| 71271 |
|
86 |
82 |
$13K |
| 01999 |
|
1,160 |
996 |
$13K |
| 77301 |
|
41 |
30 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,193 |
2,685 |
$12K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,202 |
1,082 |
$12K |
| 90715 |
|
923 |
716 |
$11K |
| 74183 |
|
41 |
40 |
$11K |
| 95700 |
|
109 |
105 |
$11K |
| 95816 |
|
92 |
84 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,058 |
15,244 |
$10K |
| 36226 |
|
32 |
30 |
$10K |
| 80061 |
Lipid panel |
1,393 |
1,198 |
$10K |
| 73630 |
|
1,511 |
1,305 |
$9K |
| 73562 |
|
820 |
716 |
$9K |
| 73130 |
|
1,125 |
970 |
$9K |
| 73030 |
|
1,250 |
1,031 |
$9K |
| 94729 |
|
181 |
168 |
$9K |
| 92610 |
|
439 |
342 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
967 |
750 |
$9K |
| 76825 |
|
57 |
52 |
$9K |
| 76937 |
|
230 |
194 |
$9K |
| 36227 |
|
58 |
30 |
$9K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
36 |
33 |
$9K |
| 81001 |
|
27,597 |
24,225 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,351 |
2,228 |
$8K |
| 96376 |
|
6,299 |
3,345 |
$8K |
| 92523 |
|
298 |
249 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
377 |
331 |
$8K |
| 94726 |
|
128 |
121 |
$8K |
| 95806 |
|
15 |
15 |
$8K |
| S9472 |
Cardiac rehabilitation program, non-physician provider, per diem |
145 |
25 |
$8K |
| 70498 |
|
667 |
563 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
487 |
408 |
$7K |
| 72040 |
|
239 |
210 |
$7K |
| 77338 |
|
54 |
43 |
$7K |
| 83735 |
|
7,168 |
4,773 |
$7K |
| 12002 |
|
62 |
53 |
$7K |
| 85027 |
|
4,041 |
2,988 |
$7K |
| 97116 |
|
360 |
204 |
$7K |
| 85610 |
|
5,899 |
4,287 |
$6K |
| 82607 |
|
926 |
722 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,749 |
2,278 |
$6K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
17 |
14 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,740 |
1,539 |
$6K |
| 87529 |
|
2,806 |
1,460 |
$6K |
| 84439 |
|
804 |
673 |
$6K |
| 73610 |
|
1,180 |
1,009 |
$6K |
| 94060 |
|
55 |
50 |
$6K |
| 73560 |
|
722 |
596 |
$5K |
| 95861 |
|
25 |
15 |
$5K |
| 83880 |
|
2,282 |
1,772 |
$5K |
| 82728 |
|
651 |
509 |
$5K |
| 96368 |
|
285 |
203 |
$5K |
| 73502 |
|
555 |
487 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
31 |
29 |
$5K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
401 |
312 |
$5K |
| 80320 |
|
795 |
627 |
$5K |
| 76827 |
|
59 |
54 |
$5K |
| 88360 |
|
154 |
81 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,581 |
3,007 |
$5K |
| 81025 |
|
14,051 |
12,401 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,696 |
4,120 |
$4K |
| 78434 |
|
224 |
195 |
$4K |
| 84702 |
|
1,384 |
1,114 |
$4K |
| 77295 |
|
13 |
12 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,740 |
1,539 |
$4K |
| 72141 |
|
30 |
26 |
$4K |
| 95937 |
|
51 |
29 |
$4K |
| 73700 |
|
48 |
38 |
$4K |
| 86140 |
|
740 |
536 |
$4K |
| 83690 |
|
14,263 |
12,041 |
$4K |
| 12011 |
|
28 |
25 |
$4K |
| 95938 |
|
52 |
30 |
$3K |
| 74174 |
|
34 |
28 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,648 |
1,463 |
$3K |
| 86780 |
|
305 |
273 |
$3K |
| 83540 |
|
716 |
560 |
$3K |
| 73110 |
|
661 |
594 |
$3K |
| 86901 |
|
2,325 |
2,001 |
$3K |
| 75635 |
|
16 |
13 |
$3K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
1,006 |
735 |
$3K |
| 76098 |
|
44 |
36 |
$3K |
| 76870 |
|
60 |
49 |
$3K |
| 76770 |
|
12 |
12 |
$3K |
| 83550 |
|
677 |
532 |
$3K |
| J7999 |
Compounded drug, not otherwise classified |
1,892 |
1,262 |
$3K |
| 00840 |
|
190 |
156 |
$2K |
| 95939 |
|
22 |
13 |
$2K |
| 95955 |
|
52 |
30 |
$2K |
| 87077 |
|
1,794 |
1,410 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
185 |
156 |
$2K |
| 76775 |
|
26 |
26 |
$2K |
| 84100 |
|
1,880 |
1,079 |
$2K |
| 83605 |
|
3,491 |
2,318 |
$2K |
| 86803 |
|
140 |
122 |
$2K |
| 64488 |
|
13 |
13 |
$2K |
| 85378 |
|
2,963 |
2,550 |
$2K |
| 87634 |
|
918 |
814 |
$2K |
| 82248 |
|
910 |
645 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
787 |
351 |
$2K |
| 88112 |
|
131 |
97 |
$2K |
| 87070 |
|
643 |
492 |
$2K |
| 82746 |
|
840 |
644 |
$2K |
| 94660 |
|
30 |
14 |
$2K |
| 73080 |
|
374 |
324 |
$2K |
| 99152 |
|
349 |
234 |
$2K |
| 73090 |
|
396 |
323 |
$1K |
| 73140 |
|
250 |
223 |
$1K |
| 87186 |
|
1,457 |
1,158 |
$1K |
| 84112 |
|
31 |
27 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,921 |
1,154 |
$1K |
| 88342 |
|
1,434 |
1,002 |
$1K |
| 84145 |
|
1,790 |
1,350 |
$1K |
| 85730 |
|
1,956 |
1,624 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$1K |
| 73590 |
|
452 |
390 |
$1K |
| 72110 |
|
34 |
32 |
$1K |
| 87340 |
|
143 |
105 |
$1K |
| 81003 |
|
3,377 |
2,903 |
$1K |
| 29125 |
|
586 |
528 |
$1K |
| 85651 |
|
1,078 |
865 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
12 |
$1K |
| 87210 |
|
1,024 |
916 |
$1K |
| 84132 |
|
1,433 |
1,083 |
$1K |
| 85014 |
|
433 |
241 |
$1K |
| 72129 |
|
30 |
24 |
$1K |
| 36430 |
|
22 |
13 |
$979.24 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,222 |
1,982 |
$976.91 |
| 72170 |
|
278 |
232 |
$973.89 |
| 97167 |
|
14 |
14 |
$899.68 |
| 87205 |
|
639 |
467 |
$895.95 |
| 82550 |
|
996 |
742 |
$891.08 |
| 85007 |
|
1,526 |
1,141 |
$828.24 |
| J8501 |
Aprepitant, oral, 5 mg |
50 |
41 |
$819.66 |
| 87040 |
|
2,884 |
1,247 |
$814.29 |
| 85018 |
|
636 |
391 |
$803.83 |
| 82575 |
|
189 |
155 |
$793.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
25,419 |
15,671 |
$749.98 |
| 82330 |
|
628 |
411 |
$707.64 |
| G0008 |
Administration of influenza virus vaccine |
88 |
55 |
$703.16 |
| 88304 |
|
762 |
590 |
$697.31 |
| 77080 |
|
13 |
12 |
$686.19 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,136 |
2,245 |
$648.36 |
| 85049 |
|
1,006 |
744 |
$647.47 |
| 71101 |
|
201 |
181 |
$629.00 |
| 36600 |
|
162 |
121 |
$628.02 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
9,120 |
6,237 |
$627.37 |
| 82140 |
|
518 |
342 |
$622.17 |
| 90686 |
|
46 |
32 |
$549.65 |
| G0238 |
Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) |
50 |
26 |
$541.88 |
| 73060 |
|
35 |
25 |
$504.20 |
| 84156 |
|
208 |
172 |
$503.72 |
| 86141 |
|
344 |
303 |
$442.64 |
| 72072 |
|
42 |
37 |
$370.84 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,010 |
1,323 |
$351.42 |
| 01400 |
|
21 |
13 |
$337.15 |
| 84703 |
|
425 |
365 |
$318.73 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,595 |
1,042 |
$257.02 |
| 73552 |
|
63 |
53 |
$247.73 |
| 86308 |
|
52 |
42 |
$233.97 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15,913 |
12,234 |
$227.19 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
680 |
538 |
$213.95 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,731 |
1,292 |
$212.98 |
| 00400 |
|
69 |
53 |
$212.23 |
| 85347 |
|
490 |
264 |
$211.60 |
| 73564 |
|
12 |
12 |
$197.64 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
597 |
435 |
$197.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,054 |
4,376 |
$195.48 |
| 82947 |
|
97 |
80 |
$190.01 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
333 |
266 |
$155.10 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
246 |
181 |
$152.18 |
| J2704 |
Injection, propofol, 10 mg |
2,431 |
1,917 |
$141.01 |
| 84481 |
|
12 |
12 |
$140.61 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
774 |
511 |
$138.17 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,696 |
2,019 |
$137.82 |
| 88311 |
|
430 |
322 |
$133.75 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,280 |
1,598 |
$123.85 |
| 82010 |
|
585 |
482 |
$122.44 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
790 |
619 |
$121.41 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,262 |
1,021 |
$121.37 |
| 83615 |
|
42 |
25 |
$115.34 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
446 |
332 |
$112.12 |
| 84550 |
|
32 |
25 |
$98.55 |
| A4648 |
Tissue marker, implantable, any type, each |
522 |
413 |
$97.56 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
322 |
191 |
$93.37 |
| J1790 |
Injection, droperidol, up to 5 mg |
928 |
716 |
$79.04 |
| 80074 |
|
14 |
14 |
$74.25 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
335 |
191 |
$73.88 |
| 36592 |
|
33 |
31 |
$71.09 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
817 |
508 |
$67.84 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,904 |
1,153 |
$66.82 |
| J2060 |
Injection, lorazepam, 2 mg |
831 |
564 |
$66.66 |
| J1940 |
Injection, furosemide, up to 20 mg |
461 |
280 |
$66.10 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
691 |
518 |
$62.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,012 |
3,472 |
$57.01 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
924 |
749 |
$54.23 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
2,141 |
1,331 |
$52.76 |
| 82565 |
|
37 |
24 |
$38.54 |
| 82040 |
|
26 |
13 |
$33.97 |
| 87075 |
|
36 |
24 |
$32.92 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
986 |
778 |
$27.68 |
| J3480 |
Injection, potassium chloride, per 2 meq |
618 |
444 |
$25.97 |
| J3360 |
Injection, diazepam, up to 5 mg |
120 |
70 |
$23.25 |
| 94761 |
|
567 |
353 |
$22.50 |
| J1630 |
Injection, haloperidol, up to 5 mg |
124 |
83 |
$20.83 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
53 |
$16.84 |
| 81015 |
|
71 |
70 |
$13.35 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
209 |
132 |
$12.55 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
798 |
536 |
$10.36 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
528 |
445 |
$8.17 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
209 |
144 |
$6.97 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
51 |
26 |
$4.34 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
206 |
127 |
$3.02 |
| J0456 |
Injection, azithromycin, 500 mg |
15 |
13 |
$2.23 |
| 94760 |
|
1,596 |
1,139 |
$2.08 |
| J2305 |
Injection, nitroglycerin, 5 mg |
36 |
36 |
$1.42 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
970 |
780 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
690 |
629 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
110 |
81 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
13 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
345 |
276 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
401 |
325 |
$0.00 |
| 00731 |
|
233 |
191 |
$0.00 |
| 00300 |
|
32 |
26 |
$0.00 |
| C1776 |
Joint device (implantable) |
200 |
132 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
204 |
133 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
75 |
53 |
$0.00 |
| C1729 |
Catheter, drainage |
167 |
125 |
$0.00 |
| 88302 |
|
17 |
13 |
$0.00 |
| 00811 |
|
20 |
16 |
$0.00 |
| C1769 |
Guide wire |
1,440 |
1,122 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
119 |
92 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
17 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
370 |
329 |
$0.00 |
| 77001 |
|
119 |
83 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
661 |
566 |
$0.00 |
| 95940 |
|
53 |
30 |
$0.00 |
| 00902 |
|
12 |
12 |
$0.00 |
| 00813 |
|
13 |
13 |
$0.00 |
| 88331 |
|
18 |
12 |
$0.00 |
| 87486 |
|
13 |
12 |
$0.00 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
283 |
246 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
25 |
14 |
$0.00 |
| 87581 |
|
13 |
12 |
$0.00 |
| 00790 |
|
13 |
13 |
$0.00 |